Fasciomyopathy: Causes, Symptoms and Treatment

What is Fasciomyopathy?

Fasciomyopathy is a term that combines two components: fascia (the connective tissue that surrounds, separates, and interconnects muscles, organs, and other body structures) and myopathy (a disease of the muscle tissue). Fasciomyopathy therefore refers to a condition in which both the fascial connective tissue and the muscle tissue are pathologically altered. This can impair normal muscle function, cause chronic pain, and lead to progressive muscle wasting.

Fascia plays a critical role in transmitting forces between muscles, stabilizing joints, and providing proprioceptive feedback (the body's sense of its own position). When fascial tissue is diseased or structurally altered, the entire musculoskeletal system can be affected.

Causes

The causes of fasciomyopathy are diverse and can be either genetic or acquired:

• Genetic causes: Certain hereditary myopathies can involve the fascial tissue, such as facioscapulohumeral muscular dystrophy (FSHD) or limb-girdle muscular dystrophy.
• Inflammatory conditions: Autoimmune diseases such as dermatomyositis, polymyositis, or eosinophilic fasciitis can affect both fascia and muscles simultaneously.
• Traumatic causes: Repetitive microtrauma, acute injuries, or chronic overuse can lead to fascial scarring and secondary muscle damage.
• Metabolic disorders: Conditions such as thyroid disease or diabetes mellitus can impair both muscle and fascial tissue.
• Idiopathic causes: In some cases, no clear underlying cause can be identified.

Symptoms

The symptoms of fasciomyopathy can vary considerably depending on the underlying cause and severity. Common complaints include:

• Muscle weakness: Particularly in the affected regions of the body (commonly the shoulders, pelvis, or limbs).
• Chronic pain: Deep, diffuse muscle and fascial pain that may worsen with physical activity.
• Restricted range of motion: Shortened or hardened fascia can reduce joint mobility.
• Muscle wasting (atrophy): A visible reduction in muscle mass can occur as the condition progresses.
• Increased muscle fatigue: Affected individuals tire more quickly than healthy people during physical activity.
• Swelling or hardening: The affected tissue may appear thickened, tense, or swollen.

Diagnosis

Diagnosing fasciomyopathy requires a thorough clinical assessment and the use of various diagnostic tools:

• Medical history and physical examination: Assessment of the patient's history, pain localization, and muscle function testing.
• Laboratory tests: Measurement of muscle enzymes (e.g., creatine kinase / CK), inflammatory markers (CRP, ESR), and autoimmune markers (ANA, specific antibodies).
• Electromyography (EMG): Measurement of electrical activity in muscles to differentiate between neurogenic and myopathic changes.
• Imaging: MRI (magnetic resonance imaging) to visualize muscles and fascia; ultrasound may also be used to assess fascial changes.
• Muscle biopsy: Collection and histopathological examination of a muscle tissue sample for precise classification of the myopathy.
• Genetic testing: Considered when a hereditary form is suspected.

Treatment

Treatment for fasciomyopathy is tailored to the underlying cause and the individual symptoms of the patient. A multidisciplinary approach is recommended in most cases:

Medical Treatment

• Immunosuppressants and corticosteroids: Used for inflammatory or autoimmune causes (e.g., cortisone, methotrexate, azathioprine).
• Pain management: Analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) to relieve pain and inflammation.
• Treatment of underlying conditions: For example, thyroid hormone replacement for hypothyroidism, or blood glucose management for diabetes.

Physiotherapy and Rehabilitation

• Targeted strength training and stretching to maintain and improve muscle function.
• Fascial therapy: Manual techniques such as myofascial release therapy, foam rolling, or osteopathic treatment to address fascial adhesions.
• Endurance training at an adapted intensity to improve overall physical fitness.

Additional Measures

• Complementary therapies such as heat application, hydrotherapy, or acupuncture may support symptom relief.
• Psychological support for individuals experiencing chronic pain conditions.
• Assistive devices (e.g., orthoses) for patients with significant muscle weakness.

Prognosis

The course of fasciomyopathy depends strongly on the underlying cause. Inflammatory forms can be significantly improved with early immunosuppressive therapy. Hereditary forms are currently not curable, but consistent physiotherapy and symptomatic treatment can slow disease progression. Early diagnosis and an individually tailored treatment plan are essential for maintaining quality of life in those affected.

References

1. Engel AG, Franzini-Armstrong C. Myology: Basic and Clinical. 3rd ed. McGraw-Hill; 2004.
2. Dalakas MC. Inflammatory muscle diseases. New England Journal of Medicine. 2015;372(18):1734-1747.
3. Stecco C. Functional Atlas of the Human Fascial System. Churchill Livingstone Elsevier; 2015.